The largest database of trusted experimental protocols

Luciferin ef

Manufactured by Promega
Sourced in United States

Luciferin-EF is a substrate for firefly luciferase, an enzyme commonly used in bioluminescent reporter assays. It provides a reliable and reproducible source of the luciferin compound, which is necessary for the luciferase-catalyzed light-emitting reaction.

Automatically generated - may contain errors

4 protocols using luciferin ef

1

Quantifying Bioluminescence Emission in Fungi

Check if the same lab product or an alternative is used in the 5 most similar protocols
To confirm the bioluminescence emission capabilities of red-shifted bioluminescent strains, serial 4-fold dilutions of fungal inoculums (1×107 initial spore count) resuspended in 200 µl of PBS and D-luciferin (final concentration 0.15 µg/ml, Luciferin-EF, Promega, USA) were transferred to a 96-well plate (Nunclon Delta-surface, Thermo Fisher Scientific, Denmark); a well without conidia (PBS+luciferin) was used as a control. BLI signal in samples was measured using an IVIS Spectrum imaging system (PerkinElmer, USA). Consecutive images were acquired for 10 min using an exposure time of 30 s (open filter, F/stop 1, subject height of 0.5 cm and medium binning). Peak total flux was quantified using Living Image Software (version 4.5.4) from a circular region of interest (ROI) of 0.8 cm diameter covering each well. Red-emission spectra (total flux) characteristics of the red-shifted luciferase were determined using a range of emission filters from 520 to 740 nm, and compared to the BL Af2/7/1 strain (green spectrum). The LOD of ungerminated conidia of each bioluminescent strain was determined as the last significant measurement (total flux) above background levels of the serial 4-fold dilutions of fungal inoculums (1×107 initial spore count) compared to control well measurements.
+ Open protocol
+ Expand
2

Quantifying Fungal Bioluminescence Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triplicate 10-fold serial dilutions of the harvested fungal suspension were prepared in a black 96-well plate (Nunc® Microwell, Thermo Fisher Scientific, Merelbeke, Belgium). An equal volume of D-luciferin solution (final concentration 0.15 µg/ml in PBS; Luciferin-EF, Promega, USA) was added. Images were acquired using an IVIS Spectrum system (Perkin Elmer, Waltham, USA) with the Living Image software (version 4.5.2) and an exposure time of 1 min, F/stop of 1 and medium binning. Individual regions of interest (ROIs) were placed over each well for quantification of the total photon flux. Afterwards, the number of CFUs per well was determined by triplicate plating of serial dilutions on Sabouraud agar, cultured as specified above.
For analysis of the emission spectra from bioluminescent C. neoformans strains, bioluminescence of the fungal suspensions was measured using emission filters from 520 to 800 nm (step size 20 nm) and an exposure time of 30 s. The observed total photon flux per emission filter was expressed relative to the total photon flux in the filter ‘open’ setting and a cubic spline curve was fitted.
+ Open protocol
+ Expand
3

CXCR4 Activation Assay in HEK293 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293 cells expressing the GloSensor (Promega, Madison, WI, USA) and CXCR4 were cultured in a black 96‐well plate (Perkin Elmer, Waltham, MA, USA) for 2–3 days until the cells were confluent. Cells were then incubated with a HBSS/20 mM HEPES/2.5% Luciferin‐EF (Promega) solution for 2 h. Luminescence was determined using a plate reader (infinite F2000PRO; Tecan, Männedorf, Switzerland) until steady state was achieved. Forskolin (1 μM) was added 28 min after the stimulus, and the luminescence was recorded.
+ Open protocol
+ Expand
4

Quantifying Circadian Rhythms in U2OS Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A stable U2OS-B6 cell line that expresses a destabilized firefly luciferase gene under the control of the mBmal1 promoter was obtained from Dr Satchidananda Panda (Vollmers et al., 2008 (link)). siRNAs targeted to LBR, LMNB1, MAN1, or SMAD1 (10 nM, Invitrogen; Carlsbad, CA; see Supplementary file 1A) were individually transfected into 35-mm culture dishes using Lipofectamine RNAiMAX (Invitrogen). For overexpression of FLAG-tagged constructs, plasmid (2 µg) was distributed into each well along with FuGENE HD (4 μl, Roche; Switzerland). For co-transfection of MAN1 siRNA and Bmal1, Lipofectamine 2000 (Invitrogen) was used. 24 hr after transfection, cells were synchronized with 100 nM dexamethasone in serum-free DMEM containing 10 mM HEPES (pH 7.5) at 37°C for 2 hr. Following synchronization, the media were replaced with phenol red-free DMEM supplemented with 10 mM HEPES and 40 µM Luciferin-EF (Promega). Cells sealed with coverslips were incubated in a 32-channel LumiCycle (Actimetrics; Evanston, IL) to monitor real-time bioluminescence for 5 days. Data were analyzed using LumiCycle Analysis (Actimetrics).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!